dexchlorpheniramine maleate (polaramine) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Dexchlorpheniramine is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria. It is the pharmacologically active dextrorotatory isomer of chlorpheniramine.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$0.0033 - $0.2520
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( phenylephrine (Prefrin), dexchlorpheniramine maleate (polaramine), ibuprofen (motrin) - other name: advil multi-symptom cold & flu )
|
( dexchlorpheniramine maleate (polaramine), ibuprofen (motrin), pseudoephedrine (Benylin) - other name: children's advil allergy sinus )
|
( dexchlorpheniramine maleate (polaramine), pseudoephedrine (Benylin) - other name: isoclor )
|
( dexchlorpheniramine maleate (polaramine), phenylpropanolamine (Propadrine) - other name: cold capsule iv )
|
( dexchlorpheniramine maleate (polaramine), codeine (Phenergan) )
|
( hydrocodone (hycodan), dexchlorpheniramine maleate (polaramine) )
|
( hydrocodone (hycodan), dexchlorpheniramine maleate (polaramine), pseudoephedrine (Benylin) )

Alternative names

1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane | 1-(p-chlorophenyl)-1-(2-pyridyl)-3-n,n-dimethylpropylamine | 2-[p-chloro-α-[2-(dimethylamino)ethyl]benzyl]pyridine | 3-(p-chlorophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine | allercalm allergy relief | allerief | alunex | antagonate | calimal | chloropheniramine | (+)-chloropheniramine | chlorophenylpyridamine | chloroprophenpyridamine | chlorphenamin | chlorphenamine | chlorphenamine maleate | chlorphenaminum | chlorpheniramine | (+)-chlorpheniramine | (+)-chlorpheniramine maleate | chlorpheniramine maleate | chlorpheniramine polistirex | chlorpheniramine tannate | chlorpheniraminum | chlorprophenpyridamine | chlorprophenpyridamine maleate | chlor-trimeton | clorfenamina | clorfeniramina | d-chlorpheniramine | d-chlorpheniramine maleate | dexchlorpheniramine | dexchlorpheniramine, (+-)-isomer | dexchlorpheniramine maleate | dexchlorpheniramine maleate (1:1), (+-)-isomer | dexchlorpheniramine maleate (1:1), (r)-isomer | dexchlorpheniramine maleate (1:1), (s)-isomer | dexchlorpheniramine monohydrochloride | dexchlorpheniramine, monohydrochloride, (s)-isomer | dexchlorpheniramine, (r)-isomer | dexchlorpheniramine sodium maleate (1:1) | dexclor | dexclorfeniramine | dextrochlorpheniramine maleate | efidac 24 chlorpheniramine maleate | gamma-(4-chlorophenyl)-n,n-dimethyl-2-pyridinepropanamine | hayleve | isoclor | kloromin | mylaramine | phenetron | piriject | piriton | piriton allergy | polaramin | polaramine | polargen td | polaronil | pyridamal 100 | rhino-syrup allergy | rimarin | s-chlorpheniramine | teldrin | γ-(4-chlorophenyl)-n,n-dimethyl-2-pyridinepropanamine | γ-(4-chlorophenyl)-γ-(2-pyridyl)propyldimethylamine

Organizations (70)

Research & Development (25)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (48)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (17)

Approved Indications (4)


 

Cough

Hypersensitivity (approved 1981)

Rhinitis, Allergic, Seasonal (approved 1950)

Sinusitis

Experimental Indications - Clinical Trial Phases 1-4 (15)


 

Common Cold (Phase 4)

Dermatitis, Atopic (Phase 2)

Healthy Volunteers (Phase 1)

Hemodynamics (Phase 3)

Hypersensitivity (Phase 3)

Insect Bites and Stings (Phase 3)

Lupus Erythematosus, Systemic (Phase 3)

Lupus Nephritis (Phase 3)

Multiple Sclerosis (Phase 3)

Prostatic Neoplasms (Phase 4)

Respiratory Tract Infections (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Seasonal (Phase 3)

Sunburn (Phase 3)

Vasoplegia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 26
  • # of Trial Organizations: 25

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue